Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Operations (Details)

v3.19.1
Organization and Nature of Operations (Details)
3 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Oct. 25, 2017
Avalon Healthcare System, Inc. [Member]      
Organization and Nature of Operations (Textual)      
Place of Incorporation Delaware    
Date of Incorporation May 18, 2015    
Percentage of Ownership 100.00%    
Principal Activities Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in United States of America ("USA")    
Avalon (BVI) Ltd. [Member]      
Organization and Nature of Operations (Textual)      
Place of Incorporation British Virgin Island    
Date of Incorporation Jan. 23, 2017    
Percentage of Ownership 100.00%    
Principal Activities Dormant, is in process of being dissolved    
Avalon RT 9 Properties LLC [Member]      
Organization and Nature of Operations (Textual)      
Place of Incorporation New Jersey    
Date of Incorporation Feb. 07, 2017    
Percentage of Ownership   100.00%  
Principal Activities Owns and operates an income-producing real property and holds and manages the corporate headquarters    
Avalon (Shanghai) Healthcare Technology Co., Ltd.      
Organization and Nature of Operations (Textual)      
Place of Incorporation PRC    
Date of Incorporation Apr. 29, 2016    
Principal Activities Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in China    
GenExosome Technologies Inc. [Member]      
Organization and Nature of Operations (Textual)      
Place of Incorporation Nevada    
Date of Incorporation Jul. 31, 2017    
Percentage of Ownership 60.00%   60.00%
Principal Activities Develops proprietary diagnostic and therapeutic products leveraging exosome technology and markets and distributes proprietary Exosome Isolation Systems in USA    
Beijing Jieteng (GenExosome) Biotech Co., Ltd. [Member]      
Organization and Nature of Operations (Textual)      
Place of Incorporation PRC    
Date of Incorporation Aug. 07, 2015    
Percentage of Ownership 100.00%    
Principal Activities Provides development services for hospitals and other customers and sells developed items to hospitals and other customers in China    
Avactis Biosciences Inc. [Member]      
Organization and Nature of Operations (Textual)      
Place of Incorporation Nevada    
Date of Incorporation Jul. 18, 2018    
Percentage of Ownership 100.00%    
Principal Activities Integrate and optimize global scientific and clinical resources to further advance cellular therapies, including regenerative medicine with stem/progenitor cells as well as cellular immunotherapy including CAR-T, CAR-NK, TCR-T and others to treat certain cancers